FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213256843> ?p ?o ?g. }

• W3213256843 endingPage "e052449" @default.
• W3213256843 startingPage "e052449" @default.
• W3213256843 abstract "The Global Platform for the Prevention of Autoimmune Diabetes-SINT1A Study is designed as a randomised, placebo-controlled, double-blind, multicentre, multinational, primary prevention study aiming to assess whether daily administration of Bifidobacterium infantis from age 7 days to 6 weeks until age 12 months to children with elevated genetic risk for type 1 diabetes reduces the cumulative incidence of beta-cell autoantibodies in childhood.Infants aged 7 days to 6 weeks from Germany, Poland, Belgium, UK and Sweden are eligible for study participation if they have a >10.0% expected risk for developing multiple beta-cell autoantibodies by age 6 years as determined by genetic risk score or family history and HLA genotype. Infants are randomised 1:1 to daily administration of B. infantis EVC001 or placebo until age 12 months and followed for a maximum of 5.5 years thereafter. The primary outcome is the development of persistent confirmed multiple beta-cell autoantibodies. Secondary outcomes are (1) Any persistent confirmed beta-cell autoantibody, defined as at least one confirmed autoantibody in two consecutive samples, including insulin autoantibodies, glutamic acid decarboxylase, islet tyrosine phosphatase 2 or zinc transporter 8, (2) Diabetes, (3) Transglutaminase autoantibodies associated with coeliac disease, (4) Respiratory infection rate in first year of life during supplementation and (5) Safety. Exploratory outcomes include allergy, antibody response to vaccines, alterations of the gut microbiome or blood metabolome, stool pH and calprotectin.The study was approved by the local ethical committees of the Technical University Munich, Medical Faculty, the Technische Universität Dresden, the Medizinische Hochschule Hannover, the Medical University of Warsaw, EC Research UZ Leuven and the Swedish ethical review authority. The results will be disseminated through peer-reviewed journals and conference presentations and will be openly shared after completion of the study.NCT04769037." @default.
• W3213256843 created "2021-11-22" @default.
• W3213256843 creator A5001453089 @default.
• W3213256843 creator A5008742337 @default.
• W3213256843 creator A5021568045 @default.
• W3213256843 creator A5026087442 @default.
• W3213256843 creator A5026837875 @default.
• W3213256843 creator A5027237131 @default.
• W3213256843 creator A5028741505 @default.
• W3213256843 creator A5029030825 @default.
• W3213256843 creator A5042336803 @default.
• W3213256843 creator A5054579366 @default.
• W3213256843 creator A5059916451 @default.
• W3213256843 creator A5061816333 @default.
• W3213256843 creator A5066994665 @default.
• W3213256843 creator A5067773219 @default.
• W3213256843 creator A5071794983 @default.
• W3213256843 creator A5076896987 @default.
• W3213256843 creator A5083462423 @default.
• W3213256843 creator A5086462994 @default.
• W3213256843 date "2021-11-01" @default.
• W3213256843 modified "2023-10-14" @default.
• W3213256843 title "Supplementation with <i>Bifidobacterium longum</i> subspecies <i>infantis</i> EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol" @default.
• W3213256843 cites W1487919162 @default.
• W3213256843 cites W1983363718 @default.
• W3213256843 cites W2012606594 @default.
• W3213256843 cites W2016073955 @default.
• W3213256843 cites W2030685032 @default.
• W3213256843 cites W2051883261 @default.
• W3213256843 cites W2090742005 @default.
• W3213256843 cites W2095256598 @default.
• W3213256843 cites W2107212470 @default.
• W3213256843 cites W2132207710 @default.
• W3213256843 cites W2158991067 @default.
• W3213256843 cites W2160926093 @default.
• W3213256843 cites W2172910482 @default.
• W3213256843 cites W2277933781 @default.
• W3213256843 cites W2343597029 @default.
• W3213256843 cites W2509121126 @default.
• W3213256843 cites W2603850261 @default.
• W3213256843 cites W2620042743 @default.
• W3213256843 cites W2620206787 @default.
• W3213256843 cites W2749021728 @default.
• W3213256843 cites W2749328728 @default.
• W3213256843 cites W2772189975 @default.
• W3213256843 cites W2795575996 @default.
• W3213256843 cites W2888577069 @default.
• W3213256843 cites W2896481903 @default.
• W3213256843 cites W2896617742 @default.
• W3213256843 cites W2909206924 @default.
• W3213256843 cites W2913087440 @default.
• W3213256843 cites W2949088599 @default.
• W3213256843 cites W2953647285 @default.
• W3213256843 cites W2956472870 @default.
• W3213256843 cites W2967343293 @default.
• W3213256843 cites W2969818069 @default.
• W3213256843 cites W2996605588 @default.
• W3213256843 cites W3032702025 @default.
• W3213256843 cites W3094521183 @default.
• W3213256843 cites W3133375349 @default.
• W3213256843 doi "https://doi.org/10.1136/bmjopen-2021-052449" @default.
• W3213256843 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8578987" @default.
• W3213256843 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34753762" @default.
• W3213256843 hasPublicationYear "2021" @default.
• W3213256843 type Work @default.
• W3213256843 sameAs 3213256843 @default.
• W3213256843 citedByCount "14" @default.
• W3213256843 countsByYear W32132568432021 @default.
• W3213256843 countsByYear W32132568432022 @default.
• W3213256843 countsByYear W32132568432023 @default.
• W3213256843 crossrefType "journal-article" @default.
• W3213256843 hasAuthorship W3213256843A5001453089 @default.
• W3213256843 hasAuthorship W3213256843A5008742337 @default.
• W3213256843 hasAuthorship W3213256843A5021568045 @default.
• W3213256843 hasAuthorship W3213256843A5026087442 @default.
• W3213256843 hasAuthorship W3213256843A5026837875 @default.
• W3213256843 hasAuthorship W3213256843A5027237131 @default.
• W3213256843 hasAuthorship W3213256843A5028741505 @default.
• W3213256843 hasAuthorship W3213256843A5029030825 @default.
• W3213256843 hasAuthorship W3213256843A5042336803 @default.
• W3213256843 hasAuthorship W3213256843A5054579366 @default.
• W3213256843 hasAuthorship W3213256843A5059916451 @default.
• W3213256843 hasAuthorship W3213256843A5061816333 @default.
• W3213256843 hasAuthorship W3213256843A5066994665 @default.
• W3213256843 hasAuthorship W3213256843A5067773219 @default.
• W3213256843 hasAuthorship W3213256843A5071794983 @default.
• W3213256843 hasAuthorship W3213256843A5076896987 @default.
• W3213256843 hasAuthorship W3213256843A5083462423 @default.
• W3213256843 hasAuthorship W3213256843A5086462994 @default.
• W3213256843 hasBestOaLocation W32132568431 @default.
• W3213256843 hasConcept C126322002 @default.
• W3213256843 hasConcept C134018914 @default.
• W3213256843 hasConcept C159654299 @default.
• W3213256843 hasConcept C163764329 @default.
• W3213256843 hasConcept C203014093 @default.
• W3213256843 hasConcept C2781232474 @default.
• W3213256843 hasConcept C555293320 @default.
• W3213256843 hasConcept C71924100 @default.

• next